Peptable

Comparison

CJC-1295 vs KPV

Also see:

CJC-1295KPV

Function

While CJC-1295 is used in research to chronically elevate endogenous growth hormone and IGF-1 levels, enabling studies of body composition, metabolic, and anti-aging effects of prolonged GH exposure10, KPV is investigated as an anti-inflammatory and barrier-protective agent in skin and mucosal models, reducing pro-inflammatory cytokines and promoting tissue repair684.

Mechanism

While CJC-1295 works as a tetrasubstituted 29-amino-acid analog of GHRH(1–29) that acts as a potent agonist at the GHRH receptor and, in its DAC form, covalently binds serum albumin to extend half-life from minutes to days, resulting in sustained pulsatile GH and IGF-1 increase1082, KPV is the C-terminal Lys-Pro-Val tripeptide fragment of α-MSH, which exerts potent anti-inflammatory effects largely via inhibition of NF-κB signaling and modulation of cytokine expression, with many actions independent of classical melanocortin receptor activation684.

Receptor

CJC-1295

Growth hormone–releasing hormone receptor (GHRHR) on anterior pituitary somatotrophs1094103

KPV

No single primary receptor; the KPV motif can influence melanocortin receptor binding profiles (MC1R–MC5R), but many anti-inflammatory effects appear melanocortin-independent684

Organism or Origin

CJC-1295

Synthetic peptide based on human hypothalamic GHRH10120

KPV

Endogenous tripeptide corresponding to positions 11–13 of human α-MSH8490

Gene

CJC-1295

GHRH

KPV

POMC

Summary

CJC-1295 and KPV are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: CJC-1295 is more often discussed in the realm of Metabolic and endocrine and Aging and longevity, whereas KPV is more often associated with the realm of Immunology and inflammation, Gastroenterology, and Dermatology and aesthetics. They also influence different molecular systems, with CJC-1295 tracking more closely to Growth hormone axis while KPV centers more on Melanocortin receptor. CJC-1295 has a more synthetic analog origin, while KPV is closer to natural endogenous background and both are still best understood as being in Preclinical development. CJC-1295 takes the form of a peptide conjugate, whereas KPV is closer to a linear peptide, CJC-1295 incorporates d-amino acid substitution features that are not part of KPV; while their sequence patterns also diverge, with CJC-1295 showing alpha-helical domain features and KPV showing protein-mimetic sequence features.

Sources

10CJC-1295: Long-Acting GHRH Analog - Alpha Carbon Labs, https://alphacarbonlabs.com/blog/cjc-1295-long-acting-ghrh-analog
82CJC-1295 no DAC 5mg (Mod GRF 1-29), https://www.peptidesciences.com/mod-grf-1-29-5mg-cjc-1295-no-dac
94Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth-hormone-releasing_hormone_receptor
103Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone_releasing_hormone_receptor
120Growth hormone–releasing hormone - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone%E2%80%93releasing_hormone
6Keratinocyte And Dermal..., https://oathresearch.com/2026/03/27/kpv-tripeptide-nfkb-inhibition-anti-inflammatory-mechanisms-cell-culture/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/